Bleeding Disorders Treatment Market
Bleeding Disorders Treatment Market Analysis By Type (Hemophilia A, Hemophilia B), By Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Fibrin Sealants), and By Region - Global Market Insights 2021-2027
Analysis of Bleeding Disorders Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bleeding Disorders Treatment Market Outlook (2021-2027)
The global bleeding disorders treatment market reached a valuation of US$ 12.7 Billion in 2020, and this industry is expected to rise at a high CAGR of 6.7% to reach US$ 19.9 Billion by the end of 2027.
The hemophilia A disease segment is projected to increase at 6.6% CAGR from 2021 to 2027. Rising awareness about the effectiveness of hemophilia A medicines is driving the complementing market growth.
Report Attributes |
Details |
|---|---|
|
Market Size (2020) |
US$ 12.7 Billion |
|
Projected Year Value (2027) |
US$ 19.9 Billion |
|
Global Market Growth Rate (2021-2027) |
6.7% CAGR |
|
China Market Growth Rate (2021-2027) |
10.1% |
|
Key Companies Profiled |
|
Revenue Analysis of Bleeding Disorders Treatment from 2017-2020 Vs Market Outlook for 2021-2027
“Growing Awareness of Bleeding Disorders across the World”
As per Fact.MR, a market research and competitive intelligence provider, the global market for bleeding disorders treatment was valued at US$ 12.7 Bn in 2020.
A bleeding disorder is a medical illness in which blood coagulation is disrupted, preventing a blood clot from forming. Internal and exterior bleeding diseases are both possible. When a person sustains an injury, blood pours out of the body. Internal bleeding occurs when blood continues to flow beneath the skin, similar to a clot in the brain.
In hemophilic individuals or people with other bleeding disorders, a bleeding disease impairs the process of blood coagulation by blocking the formation of blood clots. The majority of these bleeding problems are hereditary, although others can be acquired as a result of liver disease, pharmaceutical side effects, low red blood cell count, vitamin K insufficiency, and other factors.
A major driver for the expansion of the global bleeding disorders treatment market is high investments in R&D activities pertaining to the creation of recombinant factors, along with advances in the technology utilized to treat bleeding disorders among patients.
Considering these factors, the market is projected to witness high growth over the forecast period, registering a CAGR of 6.7% to reach US$ 19.9 Billion by 2027.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Factors Can Positively Influence Demand for Bleeding Disorders Treatment Medications?
“Growing Prevalence of Bleeding Disorders and Advancements in Treatments to Bolster Market Revenue”
The market for bleeding disorders treatment is being driven by an increase in the number of people with bleeding disorders. More than 1,125,000 males worldwide have a genetic bleeding problem, with 418,000 having a mild form of the disease that is typically undetected. Because a huge number of patients are being treated in some way, the market for bleeding disorders treatment has been rising.
Many corporations and scientific institutes have been working to develop new drugs and improve existing ones in order to boost patient awareness of therapy and adoption rates.
Many replacement medications now have easier delivery methods, lower immunogenicity, higher potency, and longer half-lives. For the past five years, bioengineering advancements have aided in the treatment of bleeding diseases. The bleeding disorders treatment market is expected to rise as a result of these developments over the coming years.
What Restraints are Being Faced by Bleeding Disorders Treatment Providers?
“Shortage of Clinicians & Unfavorable Reimbursement Situation Hampering Market Growth”
The high cost of treatment is a major roadblock in the bleeding disorders treatment market. Daily outpatient appointments, hospitalization, and lab testing all have prohibitively high prices. Other issues, such as a lack of knowledge in some developing nations, are projected to stymie the expansion of the market for acquired bleeding disorders treatments.
The dearth of skilled specialists and trained expertise would pose a significant barrier to the expansion of the bleeding disorders treatment market. The market's growth pace will be slowed by a lack of access to adequate treatment due to high prescription costs. The scope of growth will also be limited by a lack of favorable reimbursement policies.
Which Region is Expected to Lead the Global Bleeding Disorders Treatment Market?
“Accessibility to Healthcare Facilities to Propel Industry Expansion in North America”
North America is expected to lead the worldwide bleeding disorders treatment market because of its affordability and accessibility to healthcare facilities. The expansion of the market is aided by patient awareness of bleeding disorders, as well as government and private-sector treatment programs.
The market in the region is the quick continued development of enterprises working in the drug industry due to the early stage acceptance of established medical technologies. Because of the rising prevalence of various blood diseases and increased awareness among the patient population in this area, North America is likely to hold a significant market share in the blood disorders therapeutics market.
Country-wise Insights
Will the U.S. Bleeding Disorders Treatment Market Exhibit Steady Growth?
“Favorable Reimbursement & Insurance Policies Boosting Market Value”
The U.S. bleeding disorders treatment market was valued at US$ 3.4 Bn in 2020 and is expected to rise at a significant CAGR over the forecast period. According to the World Federation of Hemophilia, over 18 thousand persons in the United States have hemophilia and over 11 thousand people have Von Willebrand Disease (VWD). Hemophilia A affects 1 in every 5,000 male births, and about 400 kids are born with the disease each year.
Expansion of the bleeding disorders treatment market in the United States is aided by factors such as high rates of bleeding disorders along with favorable reimbursement and insurance policies.
Moreover, rising investments in research & development to create treatment options for blood disorders, as well as the availability of well-established healthcare infrastructure, are driving the market expansion.
Why is Demand for Bleeding Disorders Treatment Systems Surging in China?
“Rapid Availability of Drugs & Treatments Driving China Market Growth”
China, the world's second-largest economy, is expected to reach a projected market size of US$ 4.3 Bn by 2027, representing a 10.1% CAGR from 2021 to 2027. The market in China is likely to have a big revenue share in the bleeding disorders treatment market because people are becoming more aware of hereditary diseases.
Rising occurrence of bleeding disorders among patients and the availability of drugs or treatments to address these illnesses are driving market growth. The market In China is likely to benefit from factors such as increased R&D efforts and pharmaceutical companies' increased focus on creating novel drugs.
Category-wise Insights
Which Bleeding Disorders Treatment Type is Expected to Showcase Highest Growth?
“Rising R&D Expenditure on Hemophilia A Drugs & Treatments Driving Market Growth”
The hemophilia A disease segment is expected to rise at a 6.6% CAGR and reach US$ 11.1 Bn over the forecast period. The bleeding disorders treatment market is divided into hemophilia A, hemophilia B, and other forms based on type. The increased number of patients with hemophilia A and rising R&D expenditure on hemophilia medicines are driving market expansion.
The hemophilia A segment dominated the bleeding disorder treatment market in the past, and this trend is expected to continue over the forecast period. This is due to an increase in the prevalence of bleeding disorders, as well as an increase in the availability of hemophilia treatment and medications in the global hemophilia treatment market.
Which Drug Class is Expected to Gain Momentum?
“Recombinant Coagulation Factor Concentrates Gaining Traction Due to Increasing Need to Treat Blood-related Disorders”
The recombinant coagulation factor concentrates segment is predicted to increase at the fastest rate in the market. This increase can be ascribed to increased R&D activities and pharmaceutical companies' increased attention to recombinant goods, which has resulted in the launch of new medications.
Primary drivers of the segment are the rising prevalence of blood diseases and the increasing acceptance of recombinant coagulation factor concentrates. In the treatment of illnesses such as hemophilia, recombinant coagulation factor concentrates are employed (prevention and control of hemorrhagic episodes).
COVID-19 Impact on Demand for Bleeding Disorders Treatment Devices
The COVID-19 pandemic hampered the bleeding disorders treatment market. Many clinical trials for the treatment of blood diseases were impacted by the COVID-19 pandemic. In addition, hospitals cancelled hemophilia replacement procedures. Aside from that, the supply chain for bleeding disorders treatments and products was affected due to the travel ban and lockdown.
The bleeding disorders treatment market is fueled by a huge consumer base, increased knowledge of bleeding disorders and available treatments, and advantageous remuneration policies. Existing brand patents will expire, allowing generic medicine producers to access the bleeding disorder therapeutics market. Increased government initiatives and the implementation of various awareness programs are expected to support the bleeding disorders treatment market over the coming years.
Competitive Landscape
The blood disorders treatment market is competitive and fragmented, with a number of prominent companies operating in this space. In terms of market share, the industry is currently dominated by a few significant competitors.
For instance,
- In November 2020, Pfizer announced the start of the Phase III BASIS study of marstacimab, an experimental treatment for treating persons with severe hemophilia A or B. The U.S. Food and Drug Administration (FDA) granted it fast track status for use in combination with inhibitors as a potential treatment for hemophilia A and B.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Key Segments of Bleeding Disorders Treatment Industry Research
-
by Type :
- Hemophilia A
- Hemophilia B
- Other Types
-
by Drug Class :
- Plasma-derived Coagulation Factor Concentrates
- Recombinant Coagulation Factor Concentrates
- Fibrin Sealants
- Other Drug Classes
-
by Region :
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of manufacturers and providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New product launches 5.2.2. Cost of products 5.2.3. Increasing adoption of Bleeding Disorders Treatments 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as compared to 2008 Economic analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Type 6.1.4.2. Revenue By Drug Class 6.1.4.3. Revenue By Country 6.1.5. 2020 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Bleeding Disorders Treatment Market Volume (Units) Analysis 2017-2020 and Forecast, 2021-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2020 7.2. Current and Future Market Volume (Units) Projections, 2021-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Bleeding Disorders Treatment Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Bleeding Disorders Treatment Market Value Analysis 2017–2020 and Forecast, 2021-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2017–2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2021-2027 10.3.1. Hemophilia A 10.3.2. Hemophilia B 10.3.3. Other Types 10.4. Market Attractiveness Analysis By Type 11. Global Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027, by Drug Class 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Drug Class , 2017–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class , 2021-2027 11.3.1. Plasma-derived Coagulation Factor Concentrates 11.3.2. Recombinant Coagulation Factor Concentrates 11.3.3. Fibrin Sealants 11.3.4. Other Drug Classes 11.4. Market Attractiveness Analysis By Drug Class 12. Global Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2020 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Drug Class 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Drug Class 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Drug Class 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Drug Class 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Drug Class 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Drug Class 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Drug Class 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Bleeding Disorders Treatment Market Analysis 2017–2020 and Forecast 2021-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Bleeding Disorders Treatment Market Analysis 20.2.1. By Type 20.2.2. By Drug Class 20.3. Canada Bleeding Disorders Treatment Market Analysis 20.3.1. By Type 20.3.2. By Drug Class 20.4. Mexico Bleeding Disorders Treatment Market Analysis 20.4.1. By Type 20.4.2. By Drug Class 20.5. Brazil Bleeding Disorders Treatment Market Analysis 20.5.1. By Type 20.5.2. By Drug Class 20.6. U.K. Bleeding Disorders Treatment Market Analysis 20.6.1. By Type 20.6.2. By Drug Class 20.7. Germany Bleeding Disorders Treatment Market Analysis 20.7.1. By Type 20.7.2. By Drug Class 20.8. France Bleeding Disorders Treatment Market Analysis 20.8.1. By Type 20.8.2. By Drug Class 20.9. Italy Bleeding Disorders Treatment Market Analysis 20.9.1. By Type 20.9.2. By Drug Class 20.10. Spain Bleeding Disorders Treatment Market Analysis 20.10.1. By Type 20.10.2. By Drug Class 20.11. BENELUX Bleeding Disorders Treatment Market Analysis 20.11.1. By Type 20.11.2. By Drug Class 20.12. Russia Bleeding Disorders Treatment Market Analysis 20.12.1. By Type 20.12.2. By Drug Class 20.13. China Bleeding Disorders Treatment Market Analysis 20.13.1. By Type 20.13.2. By Drug Class 20.14. Japan Bleeding Disorders Treatment Market Analysis 20.14.1. By Type 20.14.2. By Drug Class 20.15. South Korea Bleeding Disorders Treatment Market Analysis 20.15.1. By Type 20.15.2. By Drug Class 20.16. India Bleeding Disorders Treatment Market Analysis 20.16.1. By Type 20.16.2. By Drug Class 20.17. ASEAN Bleeding Disorders Treatment Market Analysis 20.17.1. By Type 20.17.2. By Drug Class 20.18. Australia Bleeding Disorders Treatment Market Analysis 20.18.1. By Type 20.18.2. By Drug Class 20.19. New Zealand Bleeding Disorders Treatment Market Analysis 20.19.1. By Type 20.19.2. By Drug Class 20.20. GCC Countries Bleeding Disorders Treatment Market Analysis 20.20.1. By Type 20.20.2. By Drug Class 20.21. Turkey Bleeding Disorders Treatment Market Analysis 20.21.1. By Type 20.21.2. By Drug Class 20.22. South Africa Bleeding Disorders Treatment Market Analysis 20.22.1. By Type 20.22.2. By Drug Class 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Bayer AG 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. CSL Behring 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Grifols International SA 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Novo Nordisk A/S 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Octapharma AG 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Pfizer, Inc. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Bleeding Disorders Treatment Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Type
Table 02: Global Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 03: Global Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 04: Global Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 06: North America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 07: North America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 08: Latin America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 09: Latin America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 10: Latin America Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 11: Europe Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 12: Europe Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 13: Europe Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 14: South Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 15: South Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 16: South Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 17: East Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 18: East Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 19: East Asia Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 20: Oceania Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 21: Oceania Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 22: Oceania Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
Table 23: Middle East and Africa Bleeding Disorders Treatment Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2031, By Country
Table 24: Middle East and Africa Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 25: Middle East and Africa Bleeding Disorders Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Drug Class
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Bleeding Disorders Treatment Market Volume (in 000' Units) Analysis, 2017-2020
Figure 02: Global Bleeding Disorders Treatment Market Volume Forecast (in 000' Units), 2021-2027
Figure 03: Bleeding Disorders Treatment Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Bleeding Disorders Treatment Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 06: Global Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 07: Global Bleeding Disorders Treatment Market Absolute $ Opportunity, 2021-2027
Figure 08: Global Bleeding Disorders Treatment Market Share Analysis (%), By Type, 2021-2027
Figure 09: Global Bleeding Disorders Treatment Market Y-o-Y Analysis (%), By Type, 2021-2027
Figure 10: Global Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 11: Global Bleeding Disorders Treatment Market Share Analysis (%), By Drug Class, 2021-2027
Figure 12: Global Bleeding Disorders Treatment Market Y-o-Y Analysis (%), By Drug Class, 2021-2027
Figure 13: Global Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 14: Global Bleeding Disorders Treatment Market Share Analysis (%), By Region, 2021-2027
Figure 15: Global Bleeding Disorders Treatment Market Y-o-Y Analysis (%), By Region, 2021-2027
Figure 16: Global Bleeding Disorders Treatment Market Attractiveness Analysis by Region, 2021-2027
Figure 17: North America Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 18: North America Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 19: North America Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 20: North America Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 21: North America Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 22: North America Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 23: North America Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 24: North America Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 25: Latin America Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 27: Latin America Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 29: Latin America Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 30: Latin America Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 31: Latin America Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 32: Latin America Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 33: Europe Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 34: Europe Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 35: Europe Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 36: Europe Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 37: Europe Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 38: Europe Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 39: Europe Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 40: Europe Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 41: South Asia Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 43: South Asia Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 45: South Asia Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 46: South Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 47: South Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 48: South Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 49: East Asia Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 51: East Asia Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 53: East Asia Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 54: East Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 55: East Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 56: East Asia Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 57: Oceania Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 59: Oceania Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 61: Oceania Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 62: Oceania Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 63: Oceania Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 64: Oceania Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 65: Middle East and Africa Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 67: Middle East and Africa Bleeding Disorders Treatment Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2017-2020
Figure 69: Middle East and Africa Bleeding Disorders Treatment Market Value Forecast (US$ Mn), 2021-2027
Figure 70: Middle East and Africa Bleeding Disorders Treatment Market Attractiveness Analysis by Type, 2021-2027
Figure 71: Middle East and Africa Bleeding Disorders Treatment Market Attractiveness Analysis by Drug Class, 2021-2027
Figure 72: Middle East and Africa Bleeding Disorders Treatment Market Attractiveness Analysis by Country, 2021-2027
Figure 73: U. S. Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 76: Canada Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 78: Canada Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 79: Mexico Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 82: Brazil Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 85: U. K. Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 88: Germany Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 90: Germany Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 91: France Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 93: France Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 94: Italy Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 96: Italy Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 97: Spain Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 99: Spain Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 100: Russia Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 102: Russia Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 103: China Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 105: China Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 106: Japan Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 108: Japan Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 109: South Korea Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 112: India Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 114: India Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 115: ASEAN Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 118: Australia Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 120: Australia Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 121: New Zealand Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 124: GCC Countries Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 127: Turkey Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Figure 130: South Africa Bleeding Disorders Treatment Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Bleeding Disorders Treatment Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Bleeding Disorders Treatment Market Value Share, By Drug Class, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the sales forecast for bleeding disorders treatment?
The global market for bleeding disorders treatment is expected to be valued at US$ 19.9 Billion by 2027.
Which key growth strategies are driving bleeding disorders treatment market expansion?
Increasing prevalence of bleeding disorders and rising research and development initiatives for related treatments are driving market growth.
What was the market value for bleeding disorders treatment in 2021?
The global bleeding disorders treatment market was valued at US$ 13.5 Bn in 2021.
Which are the top 5 countries driving demand for bleeding disorders treatment products?
The U.S., Canada, Japan, China, and South Korea are expected to drive the most demand for bleeding disorders treatment products.
Who are the prominent bleeding disorders treatment equipment and drug providers?
Bayer AG, CSL Behring, Grifols International SA, Novo Nordisk A/S, and Octapharma AG are prominent bleeding disorders treatment equipment and medication providers.
Bleeding Disorders Treatment Market